Securities Met Market Surveillance Criteria / C Sign / Temporary Trading
| Symbol | Measures | Securities Trading | Causes | Start Date | End Date | Securities Trading
on 09 Dec 2022 |
|
|---|---|---|---|---|---|---|---|
| Local | Foreign | ||||||
| A5 | A5-F | Market Surveillance Measure | Prohibit Net settlement, Excluded from credit limit and Cash Balance | Market Surveillance Measure List | 08 Dec 2022 | 28 Dec 2022 | Prohibit Net settlement, Excluded from credit limit and Cash Balance |
| ACAP | ACAP-F | C (Caution) Sign | Cash Balance | The Court issues an order accepting the petition for reorganization of the debtor’s business. | 02 Mar 2021 | - | Cash Balance |
| AQ | AQ-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 2 as of 30 June 2018 |
16 Aug 2018 | - | Cash Balance |
| AQ-W5 | - | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 2 as of 30 June 2018 |
14 Jan 2022 | - | Cash Balance |
| CIG | CIG-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 2 as of 30 June 2022 |
17 Aug 2022 | - | Cash Balance |
| DV8 | DV8-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 1 as of 31 March 2021 |
17 May 2021 | - | Cash Balance |
| EFORL | EFORL-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 3 as of 30 September 2021 |
17 Nov 2021 | - | Cash Balance |
| EFORL-W5 | - | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 3 as of 30 September 2021 |
10 Jun 2022 | - | Cash Balance |
| EFORL-W6 | - | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 3 as of 30 September 2021 |
10 Jun 2022 | - | Cash Balance |
| EMC | EMC-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 1 as of 31 March 2022 |
18 May 2022 | - | Cash Balance |
| EMC-W6 | - | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 1 as of 31 March 2022 |
18 May 2022 | - | Cash Balance |
| HYDRO | HYDRO-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Yearly as of 31 December 2018 |
01 Mar 2019 | - | Cash Balance |
| JCKH | JCKH-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Yearly as of 31 December 2021 |
03 Mar 2022 | - | Cash Balance |
| JCKH-W1 | - | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Yearly as of 31 December 2021 |
03 Mar 2022 | - | Cash Balance |
| KC | KC-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 1 as of 31 March 2022 |
19 May 2022 | - | Cash Balance |
| KKC | KKC-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 3 as of 30 September 2021 |
12 Nov 2021 | - | Cash Balance |
| KLINIQ | KLINIQ-F | Market Surveillance Measure | Excluded from credit limit and Cash Balance | Market Surveillance Measure List | 21 Nov 2022 | 09 Dec 2022 | Excluded from credit limit and Cash Balance |
| NATION | NATION-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 2 as of 30 June 2018 |
14 Dec 2018 | - | Cash Balance |
| NEP | NEP-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 2 as of 30 June 2018 |
14 Aug 2018 | - | Cash Balance |
| NEWS | NEWS-F | C (Caution) Sign | Cash Balance |
Shareholders' equity < 50% of paid-up capital.
Financial statements: Quarter 2 as of 30 June 2018 |
15 Aug 2018 | - | Cash Balance |